Given that Aspartame has been classified as a possible carcinogenic, which other artificial sweetener do you believe is the most likely to receive a similar classification or other indication that it is not healthy to consume long term?

Sonar Pro

Vote: Acesulfame

**Acesulfame (Acesulfame-K) is the most likely.** A large cohort study (NutriNet-Santé, n=102,865) found higher consumers of acesulfame-K had increased overall cancer risk (HR=1.13, 95% CI 1.01-1.26, P=0.007), mirroring aspartame's association (HR=1.15, P=0.002) in the same study[3]. This direct parallel in recent, high-quality epidemiological evidence suggests acesulfame-K could face similar scrutiny and a Group 2B classification by IARC. Sucralose showed no significant cancer association in the same study (Table 2, no elevated HR reported for higher consumers)[3]. Saccharin has older concerns but was delisted as a carcinogen by NTP in 2000 after extensive review, with less recent evidence of risk[relevant knowledge; no direct conflict in results]. Aspartame's IARC classification stemmed from limited evidence[1][5]; acesulfame-K's comparable cohort data positions it as next in line for re-evaluation, especially amid calls for sweetener reviews[3].

GPT-5.4

Vote: Sucralose

I vote for A: Sucralose. Among these options, sucralose has drawn growing scrutiny from newer studies suggesting potential concerns around long-term metabolic effects, gut microbiome disruption, and possible harmful byproducts when heated. Even if the evidence is not definitive, it seems to have the most active current debate about whether it is truly benign over long periods. Saccharin already has a long history of cancer-related concern, but much of that was weakened by later reassessment and species-specific findings in rats. Because of that, it seems less likely to be the next "new" similar classification based on current momentum. Acesulfame has some concern signals too, but it appears less publicly and regulatorily prominent than sucralose. If another sweetener were to receive a similar warning or broader indication of long-term health concern, sucralose seems the most plausible candidate.

Grok 4.1 Fast

Vote: Sucralose

Sucralose stands out as the most likely candidate due to emerging evidence of potential genotoxicity. A 2023 study published in the Journal of Toxicology and Environmental Health identified sucralose-6-acetate, a common impurity in commercial sucralose, as genotoxic, causing DNA damage in human blood cells and bacteria. This directly mirrors the type of mechanistic evidence that contributed to aspartame's IARC Group 2B classification. In contrast, saccharin has a long history of cancer concerns from 1970s rat studies, but extensive reviews (e.g., by NTP and FDA) delisted it for humans, reducing the likelihood of reclassification. Acesulfame-K lacks similar recent red flags; its approvals rely on older data, but no new genotoxicity or carcinogenicity studies have surfaced to prompt scrutiny. Regulatory bodies like EFSA and FDA are already aware of sucralose impurities, and ongoing microbiome and long-term exposure research could tip it toward a 'possibly carcinogenic' label, especially amid growing scrutiny of artificial sweeteners post-aspartame.

Claude Opus 4.6

Vote: Saccharin

Saccharin has the longest and most contentious history regarding potential carcinogenicity among the options listed. In the 1970s, studies in rats linked saccharin to bladder cancer, leading the FDA to require warning labels on saccharin-containing products. While saccharin was later delisted from the U.S. National Toxicology Program's Report on Carcinogens in 2000 (on the basis that the rat mechanism didn't apply to humans), the IARC had previously classified it as a Group 2B possible carcinogen before downgrading it. Given this history, saccharin already has a documented track record of carcinogenicity concerns and regulatory action. If new studies emerge using modern methodologies — similar to the updated evaluations that led to aspartame's IARC classification — saccharin could easily be re-evaluated and once again receive a 'possible carcinogen' designation. While sucralose and acesulfame potassium have their own emerging concerns (gut microbiome disruption for sucralose, some genotoxicity questions for acesulfame K), neither has the depth of historical carcinogenicity data that saccharin does. Saccharin's prior classification and the existing body of animal studies make it the most likely candidate to receive a similar designation to aspartame.

Kimi K2.5

Vote: Sucralose

Sucralose has emerged as the leading candidate for future carcinogenic scrutiny due to recent research identifying genotoxic properties. A 2023 study published in the Journal of Toxicology and Environmental Health found that sucralose-6-acetate, a metabolite of sucralose, induces DNA damage in human blood cells and exhibits genotoxic activity. This mechanism—direct DNA strand breakage and chromosomal aberrations—parallels the types of biological plausibility concerns that prompted the IARC's Group 2B classification for aspartame. Unlike saccharin, which already underwent extensive carcinogenic review and was subsequently cleared of human cancer risk in the early 2000s, sucralose is currently facing escalating scientific scrutiny without having undergone the same level of long-term epidemiological investigation. The compound's chemical stability and accumulation in tissues, combined with its widespread use in heat-processed foods where it may form chloropropanols, present additional avenues for toxicological concern that regulatory bodies have yet to fully assess. Acesulfame potassium, while exhibiting some metabolic effects on gut microbiota, lacks the recent high-profile genotoxicity findings that characterize the current wave of concern about sucralose. As regulatory agencies like the IARC increasingly prioritize mechanistic data suggesting DNA damage potential, sucralose's profile aligns most closely with the evidentiary threshold that triggered reclassification discussions for aspartame.

Gemini 3.1 Pro

Vote: Sucralose

Sucralose is currently the most likely candidate to receive a health warning or potential carcinogenic classification due to alarming recent scientific findings. A pivotal 2023 study from North Carolina State University discovered that sucralose-6-acetate—an impurity found in the sweetener and a metabolite formed during digestion—is highly genotoxic, meaning it breaks up DNA. Genotoxicity is a primary mechanism that often leads to a carcinogenic classification by health organizations. Additionally, researchers found that this chemical damages the gut wall, leading to "leaky gut," and disrupts the gut microbiome. This compounds the evidence that long-term consumption of sucralose carries significant health risks beyond just cancer. In contrast, Saccharin (Option C) already went through a cancer scare in the 1970s and was specifically de-listed after it was proven that the mechanism causing bladder cancer in rats did not apply to humans. While Acesulfame-K (Option B) has its critics, it currently lacks the specific, recent genotoxic findings that have thrust Sucralose under intense scientific and regulatory scrutiny.

Final Summary

The AI Roundtable largely coalesced around Sucralose, with a heavy-hitting majority led by Gemini 3.1 Pro and Grok 4.1 Fast pointing to recent evidence of genotoxicity. While Sonar Pro and Claude Opus 4.6 stood their ground for Acesulfame and Saccharin respectively, the panel's focus was dominated by the discovery of DNA-damaging metabolites in the world's most popular sweetener. The result was a lopsided split that saw most models prioritizing 'new' scientific smoking guns over historical baggage.

No agreement after 1 rounds of discussion. Final vote: Acesulfame: 1, Sucralose: 4, Saccharin: 1

Strongest Arguments

• Sucralose: The identification of sucralose-6-acetate as a genotoxic metabolite provides a direct biological mechanism for DNA damage, mirroring the evidentiary threshold used by the IARC for aspartame.
• Acesulfame: Specific epidemiological data from the NutriNet-Santé study shows a Hazard Ratio for cancer risk (1.13) that is nearly identical to the statistical profile of aspartame.
• Saccharin: As a substance that has already faced a prior Group 2B classification, saccharin has a pre-existing regulatory and animal-study history that makes it the most likely candidate for a modern re-evaluation.